Skip to content
Screener

Bio-Techne TECH Gross Profit

Gross Profit at other companies

Danaher logo
DanaherDHR
$3.61B+2.5%
Bruker logo
BrukerBRKR
$416M+16.2%
10x Genomics, Inc. logo
10x Genomics, Inc.TXG
$106.18M+0.7%
Revvity logo
RevvityRVTY
$387.66M+3.2%
Agilent Technologies logo
Agilent TechnologiesA
$990M+14.3%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$309.4M+1.1%

Other financials

Income statement

See full
Revenue$311.4M-1.5%
Operating income$75.5M+95.0%
Net income$51.0M+126%
EPS (diluted)$0.32+129%

Balance sheet

See full
Cash & equivalents$209.8M+49.2%
Total debt$290.3M-31.4%
Total equity$2.1B+3.3%
Total assets$2.6B-3.5%

Cash flow

See full
Operating cash flow$86.7M+111%
CapEx$9.1M-10.2%
Free cash flow$77.6M+150%

Valuation

See full
Market cap$11.22B+43.5%
Enterprise value$11.3B+39.5%
P/E74.9×+16.9×
P/S9.3×+2.9×

Profitability

See full
Gross margin65%-0.8pp
Operating margin14.2%-7.9pp
Net margin10.9%-6.7pp
FCF margin22.3%+4.0pp

Returns & leverage

See full
Return on equity6.5%-3.9pp
Debt / equity0.1×-0.1×
Current ratio4.5×+0.8×

Where this comes from

Calculated from Bio-Techne’s reported figures.

The source filing: Bio-Techne’s 10-Q, filed May 6, 2026.

Filed
May 6, 2026, 4:31 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-056302
Line itemQuarter Ended / March 31, 2026Quarter Ended / March 31, 2025Nine Months Ended / March 31, 2026Nine Months Ended / March 31, 2025
Net sales$311,415$316,181$893,847$902,671
Cost of sales103,127101,625306,170311,211
Gross margin208,288214,556587,677591,460
Operating expenses:
Selling, general and administrative109,338151,269339,242391,881
Research and development23,45524,57970,82173,464
Total operating expenses132,793175,848410,063465,345
Operating income75,49538,708177,614126,115

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Bio-Techne's gross profit?
Bio-Techne (TECH) reported gross profit of $208.29M in Q1 2026.
How has Bio-Techne's gross profit changed year-over-year?
Bio-Techne's gross profit decreased by 2.9% year-over-year, from $214.56M to $208.29M.
What is the long-term trend for Bio-Techne's gross profit?
Over 3 years (2022 to 2025), Bio-Techne's gross profit has grown at a 1.5% compound annual growth rate (CAGR), from $756.5M to $790.27M.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.

Ask your AI about Bio-Techne's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude